Evidence map›Paper›PMID 40976486›Full record

ArticleTransplantation and cellular therapy2026

Exploring Perspectives on Feasibility, Challenges, and Support Needs for Chlorhexidine Gluconate (CHG) Bathing in the Outpatient Setting for Hematopoietic Cell Transplant Recipients: A Qualitative Study.

Marie-Michèle Sainvil, Ashley L Artese, Laura J Fish, Chukwuamaka M Onyewadume, Joane Titus, Safia Gecaj, Lauren Hill, Tamara Somers, Anita Matthews, Deborah H Allen and 11 more

Abstract read
In one paragraph

Article in Transplantation and cellular therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Marie-Michèle SainvilDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina. Electronic address: michele.sainvil@duke.edu.
Ashley L ArteseDepartment of Exercise Science and Health Promotion, Florida Atlantic University, Boca Raton, Florida; Center for the Study of Aging and Human Development, Duke University School of Medicine, Durham, North Carolina.
Laura J FishDepartment of Family Medicine and Community Health, Duke University School of Medicine, and Duke Cancer Institute Behavioral Health and Survey Research core, Durham, North Carolina.
Chukwuamaka M OnyewadumeDepartment of Epidemiology, George Washington University, Milken Institute School of Public Health, Washington, District of Columbia.
Joane TitusDepartment of Internal Medicine, University of Central Florida College of Medicine, Orlando, Florida.
Safia GecajDepartment of Exercise Science and Health Promotion, Florida Atlantic University, Boca Raton, Florida.
Lauren HillDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina.
Tamara SomersDepartment of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina.
Anita MatthewsDuke University Health System Nursing, Durham, North Carolina.
Deborah H AllenDuke University Health System Nursing, Durham, North Carolina.
Elizabeth SitoDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina.
Tessa M AndermannDivision of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Andrew R RezvaniDivision of Blood & Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, California.
Taewoong ChoiDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina.
Mitchell E HorwitzDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina.
Richard D LopezDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina.
David A RizzieriNovant Health, Winston Salem, North Carolina.
Stefanie SarantopoulosDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina.
Nelson J ChaoDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina.
Sanghee HongDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina; Department of Population Health Sciences, School of Medicine, Duke University, Durham, North Carolina.
Anthony D SungDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina; Center for the Study of Aging and Human Development, Duke University School of Medicine, Durham, North Carolina; Division of Hematologic Malignancies and Cellular Therapy, Kansas University, Kansas City, Kansas.

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI Laura Fish · 1985 to 2026
$174.8M
TRANSFUSION MEDICINE AND RELATED AREAST32HL007057 · NHLBI · DUKE UNIVERSITY · PI Gowthami M Arepally · 1985 to 2026
$10.6M
BEHAVIOR AND PHYSIOLOGY IN AGINGT32AG000029 · NIA · DUKE UNIVERSITY · PI Maria Marquine · 1985 to 2026
$9.3M
Precision characterization of antimicrobial resistance gene dynamics in bloodstream infection risk after hematopoietic stem cell transplantationK23AI163365 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ANDERMANN, TESSA · 2021 to 2025
$1.0M
NCI NIH HHS P30 CA014236NHLBI NIH HHS T32 HL007057NIAID NIH HHS K23 AI163365NIA NIH HHS T32 AG000029
6 · The paper itself

Abstract

backgroundChlorhexidine gluconate (CHG) bathing is recommended for infection prevention in hematopoietic cell transplantation (HCT) patients. As more centers transition HCT care to outpatient settings, understanding patients' perceptions of CHG bathing feasibility, support needs, and home-based barriers in the home environment is critical to promoting adherence.

objectiveThis study explores HCT patient perceptions regarding feasibility of CHG bathing in the outpatient setting to identify barriers and support needs. STUDY

designWe conducted a qualitative descriptive study with 14 HCT (mean 51±16 years) recipients recruited from an inpatient transplant unit. Semi-structured interviews were conducted via phone, video, or in person within three months post-discharge. A rapid qualitative analysis approach was used to identify key sub-themes related to feasibility, challenges, and needed support.

resultsParticipants supported the feasibility of CHG bathing in the outpatient setting and were supportive of its continued use post-discharge. Participants sited potential challenges including lack of motivation, home management difficulties, and administration concerns. Participants identified the need for structured reminders and accountability, caregiver support, and clinical follow-up. The importance of education emerged as a salient theme. Suggestions for improving adherence included integrating CHG bathing into daily routines and enhancing patient education.

conclusionWhile CHG bathing in the outpatient setting is feasible, targeted interventions, such as education, reminders, and caregiver involvement may improve adherence and optimize infection prevention. Findings from this study can inform the application of CHG in the outpatient setting and development of innovative, patient-driven strategies to improve CHG adherence. Future efforts should focus on addressing identified barriers to support successful outpatient implementation.

Indexed as

Anti-Infective Agents, LocalBathsChlorhexidineHematopoietic Stem Cell TransplantationAdultAgedFeasibility StudiesFemaleHumansMaleMiddle AgedOutpatientsQualitative ResearchAnti-Infective Agents, LocalChlorhexidinechlorhexidine gluconateChlorhexidine gluconatehematopoietic cell transplantationinfection riskqualitative research

Identifiers

PMID40976486
PMCPMC12866602

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.